Treatment of Osteo-arthritis of the Hip with Indomethacin

Open Access
Publisher Website
Google Scholar
Abstract
A double-blind crossover trial of 4 weeks with indomethacin in a dosage of 75-150 mg per day, against a placebo, showed a significant preference for indomethacin both subjectively as regards effort and rest pain and objectively as regards the range of abduction of the hips. The new formulation and a lower dosage of this drug contributed to the reduced incidence of adverse and toxic effects.

This publication has 3 references indexed in Scilit: